hiv preventionlatest news & developments
What’s the best way to spend the HIV prevention budget so that the country can drive infections down as fast as possible? We take a look at what modelling data shows. (Pexels, kaboompics)

180 000 infections in 2024, 47 000 by 2045 — if SA rolls out the twice-a-year HIV prevention jab fast enough

The HIV prevention shot, lenacapavir, will be rolled out at South African clinics within the next couple of months and from 2027, the health department will also buy generics. But how best to spend the HIV prevention budget so that the country can drive infections down as fast as possible? We take a look at what the modelling data shows

  • Eyaaz
9 min read
After a year of US funding cuts across global public health, including South Africa’s hard-hit HIV programmes, new realities are settling in. We spoke to Mitchell Warren from the New York HIV advocacy organisation, Avac, to find out what that means for South Africa. Photo: Paul Botes

What will HIV funding look like in 2026?

After a year of US funding cuts across global public health, including South Africa’s hard-hit HIV programmes, new realities are settling in

  • Eyaaz
9 min read
We talked to experts about their take on a few of the most pressing public health issues this year. (Jay Caboz)

Here’s what’s on South Africa’s 2026 public health agenda

We talked to experts in obesity, tobacco, artificial intelligence, HIV, TB and the NHI to find out what we can expect — and what we can’t — this year

  • Eyaaz
18 min read
Circumcision has been shown in large clinical trials to be effective at reducing the risk of HIV transmission. But devices need to be thoroughly tested for safety before they are used. Photo of a scalpal: Wikimedia user Rickyblax (CC BY-SA 4.0)

KZN rolls out controversial circumcision device amid safety concerns

The safety and track record of the CircumQ devices has been questioned

  • Eyaaz
5 min read
Who should get SA’s first batch of lenacapavir jabs? Here’s how different scenarios compare. (Mufid Majnun/Unsplash)

SA’s first batch of LEN jabs will arrive in February. Use Bhekisisa’s dashboard to find out who should get them

Who should get what slice of the pie once the medicine is available in public clinics? And are numbers alone what would drive decisions?

  • Eyaaz
11 min read
Two Indian generic drugmakers — Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot around R692 per person per year. (Anna-Maria van Niekerk)

Two drugmakers will sell the 6-monthly anti-HIV jab for the price of the daily prevention pill

Hetero and Dr Reddy’s will be funded by the Gates Foundation and Unitaid to produce and sell the twice-a-year anti-HIV shot around R692 per person a year

  • Eyaaz
9 min read
The US government’s Aids fund, Pepfar, has donated 231 000 doses over two years to South Africa — 96 000 of the doses will arrive between October and December, enough for 13 728 people to use to protect themselves against HIV infection for one year.

South Africa to roll out HIV prevention injection CAB-LA in clinics, with US donation

CAB-LA virtually eliminates someone’s chances of contracting HIV, but costs about four times more than the government can afford to pay

  • Des Erasmus
5 min read